Entecavir Plus Adefovir in Lamivudine-Resistant Patients

PHASE4WithdrawnINTERVENTIONAL

Timeline

Start Date

December 31, 2009

Primary Completion Date

December 31, 2012

Study Completion Date

June 30, 2014

Conditions

Hepatitis B, Chronic

Interventions

DRUG

Lamivudine

Tablets, Oral, 100mg, once daily, 48-96 weeks depending on response

DRUG

Entecavir

Tablets, Oral, 1mg, once daily, 48-96 weeks depending on response

DRUG

Adefovir

Tablets, Oral, 10mg, once daily, 48-96 weeks depending on response